Innate Pharma SA (FR:IPH) has released an update.
Innate Pharma SA, a leading biotech firm specializing in immunotherapies for cancer, has scheduled a conference call and webcast to discuss its financial results and business progress for the first half of 2024. The event, featuring key executives including the CEO and CFO, is set for September 12, 2024, and will be accessible both via webcast and telephone. The company, known for its partnerships with industry giants and innovative ANKET platform, continues to advance its key programs in cancer treatment.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.
